425: Strive and Semler Scientific Merger Filing

Strive, Inc. filed a Form 425 related to its proposed business combination with Semler Scientific, Inc., including cautionary statements regarding forward-looking information and associated risks.

Summary

• Strive, Inc. filed a Form 425 with the SEC concerning its proposed business combination with Semler Scientific, Inc.
• The filing references an investor presentation posted on Strive's website on November 10, 2025.
• The document primarily serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• It outlines various risks and uncertainties that could cause actual results to differ materially from anticipated results.
• Information is provided on where to find additional details about the proposed transaction, including the Registration Statement on Form S-4.

Sentiment

Score: 4

Explanation: The filing is primarily a cautionary statement regarding a proposed business combination, heavily emphasizing risks and uncertainties. While the underlying event (a merger) can be positive, this specific document's tone is neutral to cautious due to its legal disclosure nature and focus on potential negative outcomes and uncertainties.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

Forward-looking statements are subject to significant risks and uncertainties, and there is no assurance that actual results will not differ materially from any projected future results. Investors are cautioned not to rely too heavily on such statements.

Management Comments

• Forward-looking statements are based on assumptions as of the time they are made and are subject to risks, uncertainties and other factors that are difficult to predict.
• Although each of Strive and Semler Scientific believes that its expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of its existing knowledge of its business and operations, there can be no assurance that actual results will not differ materially.
• Investors are cautioned not to rely too heavily on any such forward-looking statements.

Legal Proceedings

• Risk of legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock for existing shareholders.

Next Steps

• Strive has filed a Registration Statement on Form S-4, which includes an information statement, proxy statement, and prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Business Combination, Merger, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury Strategy, Digital Assets, Corporate Governance